142 related articles for article (PubMed ID: 33477971)
1. Semi-Quantitative Characterization of Post-Transplant Lymphoproliferative Disorder Morphological Subtypes with [
Montes de Jesus F; Vergote V; Noordzij W; Dierickx D; Dierckx RAJO; Diepstra A; Tousseyn T; Gheysens O; Kwee TC; Deroose CM; Glaudemans AWJM
J Clin Med; 2021 Jan; 10(2):. PubMed ID: 33477971
[No Abstract] [Full Text] [Related]
2. The value of
Si Z; Lu D; Zhai L; Zheng W; Dong C; Sun C; Wang K; Zhang W; Wei X; Zhang Z; Zhao S; Gao W; Shen Z
Pediatr Transplant; 2023 Aug; 27(5):e14501. PubMed ID: 36906739
[TBL] [Abstract][Full Text] [Related]
3.
Montes de Jesus FM; Glaudemans AWJM; Tissing WJ; Dierckx RAJO; Rosati S; Diepstra A; Noordzij W; Kwee TC
J Nucl Med; 2020 Sep; 61(9):1307-1313. PubMed ID: 32005775
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic and management roles of FDG PET/CT imaging in post-transplant lympho-proliferation in pediatric heart transplantation.
Brown AK; Carapellucci J; Oshrine B; Gomez A; Meoded A; Asante-Korang A
Clin Transplant; 2023 Sep; 37(9):e15015. PubMed ID: 37237443
[TBL] [Abstract][Full Text] [Related]
5. The role of
Wang C; Wang G; Wang W; Kan Y; Zhang M; Yang J
Quant Imaging Med Surg; 2024 Feb; 14(2):1323-1334. PubMed ID: 38415126
[TBL] [Abstract][Full Text] [Related]
6. (18)F-FDG PET/CT in the management of patients with post-transplant lymphoproliferative disorder.
Takehana CS; Twist CJ; Mosci C; Quon A; Mittra E; Iagaru A
Nucl Med Commun; 2014 Mar; 35(3):276-81. PubMed ID: 24296883
[TBL] [Abstract][Full Text] [Related]
7. The value of 18F-FDG PET in pediatric patients with post-transplant lymphoproliferative disorder at initial diagnosis.
Vali R; Punnett A; Bajno L; Moineddin R; Shammas A
Pediatr Transplant; 2015 Dec; 19(8):932-9. PubMed ID: 26515450
[TBL] [Abstract][Full Text] [Related]
8. Image findings of monomorphic non-hogdkin lymphoproliferative disorder in a post renal transplant patient diagnosed with fluorine-18 fluorodeoxyglucose-positron emission tomography/computed tomography.
Kamaleshwaran KK; Rajasekar T; Shibu D; Radhakrishnan EK; Shinto AS
Indian J Nucl Med; 2014 Jul; 29(3):189-90. PubMed ID: 25210292
[TBL] [Abstract][Full Text] [Related]
9.
Chen J; Zhang X; Ma L; Gao Y; Fu Z; Liu M
Front Med (Lausanne); 2023; 10():1258310. PubMed ID: 37663666
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic performance of FDG-PET/CT of post-transplant lymphoproliferative disorder and factors affecting diagnostic yield.
Montes de Jesus FM; Kwee TC; Kahle XU; Nijland M; van Meerten T; Huls G; Dierckx RAJO; Rosati S; Diepstra A; van der Bij W; Verschuuren EAM; Glaudemans AWJM; Noordzij W
Eur J Nucl Med Mol Imaging; 2020 Mar; 47(3):529-536. PubMed ID: 31444510
[TBL] [Abstract][Full Text] [Related]
11. Detection of bone marrow involvement in newly diagnosed post-transplant lymphoproliferative disorder: (18)F-fluorodeoxyglucose positron emission tomography/computed tomography versus bone marrow biopsy.
Gheysens O; Thielemans S; Morscio J; Boeckx N; Goffin KE; Deroose CM; Sagaert X; Wlodarska I; Verhoef G; Dierickx D; Tousseyn T
Leuk Lymphoma; 2016 Oct; 57(10):2382-8. PubMed ID: 26854937
[TBL] [Abstract][Full Text] [Related]
12. Hodgkin lymphoma post-transplant lymphoproliferative disorder following pediatric renal transplant: serial imaging with F-18 FDG PET/CT.
Makis W; Lisbona R; Derbekyan V
Clin Nucl Med; 2010 Sep; 35(9):704-5. PubMed ID: 20706047
[TBL] [Abstract][Full Text] [Related]
13. Semi-automated
Keijzer K; Niezink AGH; de Boer JW; van Doesum JA; Noordzij W; van Meerten T; van Dijk LV
Comput Struct Biotechnol J; 2023; 21():1102-1114. PubMed ID: 36789266
[TBL] [Abstract][Full Text] [Related]
14. Metabolic Tumor Burden Assessed by Dual Time Point [
Garcia-Vicente AM; Pérez-Beteta J; Pérez-García VM; Molina D; Jiménez-Londoño GA; Soriano-Castrejón A; Martínez-González A
Mol Imaging Biol; 2017 Aug; 19(4):636-644. PubMed ID: 27981471
[TBL] [Abstract][Full Text] [Related]
15. Prognostic superiority of International Prognostic Index over [
Montes de Jesus F; Dierickx D; Vergote V; Noordzij W; Dierckx RAJO; Deroose CM; Glaudemans AWJM; Gheysens O; Kwee TC
EJNMMI Res; 2021 Mar; 11(1):29. PubMed ID: 33738643
[TBL] [Abstract][Full Text] [Related]
16. Performance of advanced imaging modalities at diagnosis and treatment response evaluation of patients with post-transplant lymphoproliferative disorder: A systematic review and meta-analysis.
Montes de Jesus FM; Kwee TC; Nijland M; Kahle XU; Huls G; Dierckx RAJO; van Meerten T; Gheysens O; Dierickx D; Vergote V; Noordzij W; Glaudemans AWJM
Crit Rev Oncol Hematol; 2018 Dec; 132():27-38. PubMed ID: 30447925
[TBL] [Abstract][Full Text] [Related]
17. Lymph node standardized uptake values at pre-treatment
Jeong Y; Baek S; Park JW; Joo JH; Kim JS; Lee SW
Br J Radiol; 2017 Mar; 90(1071):20160239. PubMed ID: 28008776
[TBL] [Abstract][Full Text] [Related]
18. Utility of FDG PET/CT in the Characterization of Sinonasal Neoplasms: Analysis of Standardized Uptake Value Parameters.
Ozturk K; Gencturk M; Caicedo-Granados E; Li F; Cayci Z
AJR Am J Roentgenol; 2018 Dec; 211(6):1354-1360. PubMed ID: 30300005
[TBL] [Abstract][Full Text] [Related]
19. Clinical usefulness of FDG-PET/CT scan imaging in the management of posttransplant lymphoproliferative disease.
Bianchi E; Pascual M; Nicod M; Delaloye AB; Duchosal MA
Transplantation; 2008 Mar; 85(5):707-12. PubMed ID: 18337664
[TBL] [Abstract][Full Text] [Related]
20. Comparison of prone versus supine 18F-FDG-PET of locally advanced breast cancer: Phantom and preliminary clinical studies.
Williams JM; Rani SD; Li X; Arlinghaus LR; Lee TC; MacDonald LR; Partridge SC; Kang H; Whisenant JG; Abramson RG; Linden HM; Kinahan PE; Yankeelov TE
Med Phys; 2015 Jul; 42(7):3801-13. PubMed ID: 26133582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
